Annual Current Liabilities
$13.84 B
-$1.65 B-10.64%
31 December 2023
Summary:
Abbott Laboratories annual total current liabilities is currently $13.84 billion, with the most recent change of -$1.65 billion (-10.64%) on 31 December 2023. During the last 3 years, it has risen by +$1.93 billion (+16.24%). ABT annual current liabilities is now -19.82% below its all-time high of $17.26 billion, reached on 31 December 2010.ABT Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$14.90 B
+$1.14 B+8.30%
30 September 2024
Summary:
Abbott Laboratories quarterly total current liabilities is currently $14.90 billion, with the most recent change of +$1.14 billion (+8.30%) on 30 September 2024. Over the past year, it has increased by +$1.86 billion (+14.26%). ABT quarterly current liabilities is now -13.67% below its all-time high of $17.26 billion, reached on 31 December 2010.ABT Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABT Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.6% | +14.3% |
| 3 y3 years | +16.2% | +15.8% |
| 5 y5 years | +53.6% | +42.0% |
ABT Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -10.6% | +16.2% | -3.8% | +20.3% |
| 5 y | 5 years | -10.6% | +53.6% | -3.8% | +45.3% |
| alltime | all time | -19.8% | +1655.4% | -13.7% | +1789.9% |
Abbott Laboratories Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $14.90 B(+8.3%) |
| June 2024 | - | $13.76 B(-1.9%) |
| Mar 2024 | - | $14.02 B(+1.3%) |
| Dec 2023 | $13.84 B(-10.6%) | $13.84 B(+6.1%) |
| Sept 2023 | - | $13.04 B(-9.1%) |
| June 2023 | - | $14.35 B(-1.2%) |
| Mar 2023 | - | $14.53 B(-6.2%) |
| Dec 2022 | $15.49 B(+18.2%) | $15.49 B(+15.9%) |
| Sept 2022 | - | $13.37 B(+7.9%) |
| June 2022 | - | $12.39 B(-2.0%) |
| Mar 2022 | - | $12.65 B(-3.5%) |
| Dec 2021 | $13.11 B(+10.1%) | $13.11 B(+1.8%) |
| Sept 2021 | - | $12.87 B(+2.0%) |
| June 2021 | - | $12.61 B(+1.2%) |
| Mar 2021 | - | $12.46 B(+4.7%) |
| Dec 2020 | $11.91 B(+9.6%) | $11.91 B(+16.1%) |
| Sept 2020 | - | $10.26 B(-6.4%) |
| June 2020 | - | $10.96 B(+1.4%) |
| Mar 2020 | - | $10.81 B(-0.5%) |
| Dec 2019 | $10.86 B(+20.5%) | $10.86 B(+3.5%) |
| Sept 2019 | - | $10.49 B(+15.8%) |
| June 2019 | - | $9.06 B(-0.6%) |
| Mar 2019 | - | $9.11 B(+1.1%) |
| Dec 2018 | $9.01 B(+1.1%) | $9.01 B(-29.5%) |
| Sept 2018 | - | $12.78 B(+42.7%) |
| June 2018 | - | $8.95 B(-0.7%) |
| Mar 2018 | - | $9.01 B(+1.1%) |
| Dec 2017 | $8.91 B(+33.8%) | $8.91 B(+12.3%) |
| Sept 2017 | - | $7.93 B(+16.6%) |
| June 2017 | - | $6.80 B(+2.4%) |
| Mar 2017 | - | $6.65 B(-0.2%) |
| Dec 2016 | $6.66 B(-27.5%) | $6.66 B(-20.0%) |
| Sept 2016 | - | $8.32 B(-4.1%) |
| June 2016 | - | $8.67 B(+3.3%) |
| Mar 2016 | - | $8.39 B(-8.6%) |
| Dec 2015 | $9.19 B(-12.2%) | $9.19 B(+4.9%) |
| Sept 2015 | - | $8.76 B(-4.7%) |
| June 2015 | - | $9.19 B(-0.2%) |
| Mar 2015 | - | $9.21 B(-12.0%) |
| Dec 2014 | $10.47 B(+10.1%) | $10.47 B(-3.3%) |
| Sept 2014 | - | $10.82 B(+9.8%) |
| June 2014 | - | $9.85 B(-3.3%) |
| Mar 2014 | - | $10.19 B(+7.1%) |
| Dec 2013 | $9.51 B(-28.4%) | $9.51 B(-16.1%) |
| Sept 2013 | - | $11.33 B(+3.8%) |
| June 2013 | - | $10.92 B(+4.9%) |
| Mar 2013 | - | $10.41 B(-21.6%) |
| Dec 2012 | $13.28 B(-14.2%) | $13.28 B(-18.5%) |
| Sept 2012 | - | $16.29 B(-4.9%) |
| June 2012 | - | $17.12 B(+2.0%) |
| Mar 2012 | - | $16.79 B(+8.4%) |
| Dec 2011 | $15.48 B(-10.3%) | $15.48 B(+0.4%) |
| Sept 2011 | - | $15.41 B(-2.7%) |
| June 2011 | - | $15.84 B(-8.0%) |
| Mar 2011 | - | $17.23 B(-0.2%) |
| Dec 2010 | $17.26 B(+32.3%) | $17.26 B(+10.8%) |
| Sept 2010 | - | $15.58 B(+6.1%) |
| June 2010 | - | $14.69 B(-3.3%) |
| Mar 2010 | - | $15.18 B(+16.4%) |
| Dec 2009 | $13.05 B(+12.6%) | $13.05 B(+4.2%) |
| Sept 2009 | - | $12.52 B(+4.0%) |
| June 2009 | - | $12.04 B(+2.3%) |
| Mar 2009 | - | $11.77 B(+1.5%) |
| Dec 2008 | $11.59 B(+27.3%) | $11.59 B(+21.3%) |
| Sept 2008 | - | $9.56 B(-20.4%) |
| June 2008 | - | $12.02 B(+11.6%) |
| Mar 2008 | - | $10.77 B(+18.3%) |
| Dec 2007 | $9.10 B(-23.8%) | $9.10 B(-25.9%) |
| Sept 2007 | - | $12.28 B(+2.3%) |
| June 2007 | - | $12.01 B(-2.4%) |
| Mar 2007 | - | $12.31 B(+3.0%) |
| Dec 2006 | $11.95 B | $11.95 B(+60.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2006 | - | $7.43 B(-3.4%) |
| June 2006 | - | $7.69 B(+7.5%) |
| Mar 2006 | - | $7.16 B(-3.4%) |
| Dec 2005 | $7.42 B(+8.6%) | $7.42 B(-15.3%) |
| Sept 2005 | - | $8.76 B(+44.0%) |
| June 2005 | - | $6.08 B(-17.4%) |
| Mar 2005 | - | $7.37 B(+7.9%) |
| Dec 2004 | $6.83 B(-2.0%) | $6.83 B(-6.4%) |
| Sept 2004 | - | $7.30 B(-4.3%) |
| June 2004 | - | $7.62 B(+9.6%) |
| Mar 2004 | - | $6.95 B(-0.1%) |
| Dec 2003 | $6.96 B(-0.6%) | $6.96 B(-13.4%) |
| Sept 2003 | - | $8.04 B(+9.6%) |
| June 2003 | - | $7.33 B(+5.6%) |
| Mar 2003 | - | $6.94 B(-0.8%) |
| Dec 2002 | $7.00 B(-11.7%) | $7.00 B(+4.2%) |
| Sept 2002 | - | $6.72 B(-2.2%) |
| June 2002 | - | $6.87 B(-1.2%) |
| Mar 2002 | - | $6.95 B(-12.3%) |
| Dec 2001 | $7.93 B(+84.5%) | $7.93 B(+1.9%) |
| Sept 2001 | - | $7.78 B(+5.0%) |
| June 2001 | - | $7.41 B(-32.0%) |
| Mar 2001 | - | $10.89 B(+153.4%) |
| Dec 2000 | $4.30 B(-4.9%) | $4.30 B(+0.3%) |
| Sept 2000 | - | $4.28 B(+2.3%) |
| June 2000 | - | $4.19 B(-6.9%) |
| Mar 2000 | - | $4.50 B(-0.4%) |
| Dec 1999 | $4.52 B(-9.0%) | $4.52 B(+4.3%) |
| Sept 1999 | - | $4.33 B(+3.8%) |
| June 1999 | - | $4.17 B(-11.4%) |
| Mar 1999 | - | $4.71 B(-5.2%) |
| Dec 1998 | $4.97 B(-1.4%) | $4.97 B(+6.5%) |
| Sept 1998 | - | $4.66 B(-6.7%) |
| June 1998 | - | $5.00 B(+5.8%) |
| Mar 1998 | - | $4.73 B(-6.1%) |
| Dec 1997 | $5.03 B(+15.9%) | $5.03 B(+6.6%) |
| Sept 1997 | - | $4.72 B(+4.6%) |
| June 1997 | - | $4.51 B(+3.1%) |
| Mar 1997 | - | $4.38 B(+0.8%) |
| Dec 1996 | $4.34 B(+14.6%) | $4.34 B(+1.3%) |
| Sept 1996 | - | $4.29 B(-5.3%) |
| June 1996 | - | $4.53 B(+29.7%) |
| Mar 1996 | - | $3.49 B(-7.9%) |
| Dec 1995 | $3.79 B(+9.0%) | $3.79 B(+6.3%) |
| Sept 1995 | - | $3.57 B(+0.9%) |
| June 1995 | - | $3.54 B(-1.5%) |
| Mar 1995 | - | $3.59 B(+3.3%) |
| Dec 1994 | $3.48 B(+12.3%) | $3.48 B(+2.0%) |
| Sept 1994 | - | $3.41 B(+4.2%) |
| June 1994 | - | $3.27 B(+7.0%) |
| Mar 1994 | - | $3.05 B(-1.3%) |
| Dec 1993 | $3.09 B(+11.2%) | $3.09 B(-0.7%) |
| Sept 1993 | - | $3.12 B(+1.7%) |
| June 1993 | - | $3.06 B(+2.1%) |
| Mar 1993 | - | $3.00 B(+7.9%) |
| Dec 1992 | $2.78 B(+24.8%) | $2.78 B(+3.7%) |
| Sept 1992 | - | $2.68 B(+15.8%) |
| June 1992 | - | $2.32 B(+2.8%) |
| Mar 1992 | - | $2.25 B(+1.1%) |
| Dec 1991 | $2.23 B(+11.4%) | $2.23 B(+8.0%) |
| Sept 1991 | - | $2.06 B(-0.3%) |
| June 1991 | - | $2.07 B(+1.4%) |
| Mar 1991 | - | $2.04 B(+2.0%) |
| Dec 1990 | $2.00 B(+44.6%) | $2.00 B(-8.3%) |
| Sept 1990 | - | $2.18 B(+15.0%) |
| June 1990 | - | $1.90 B(+14.5%) |
| Mar 1990 | - | $1.66 B(+19.7%) |
| Dec 1989 | $1.38 B(-3.9%) | $1.38 B(-3.9%) |
| Dec 1988 | $1.44 B(-3.2%) | $1.44 B(-3.2%) |
| Dec 1987 | $1.49 B(+14.1%) | $1.49 B(+14.1%) |
| Dec 1986 | $1.30 B(+65.3%) | $1.30 B(+65.3%) |
| Dec 1985 | $788.50 M(-2.2%) | $788.50 M(-2.2%) |
| Dec 1984 | $806.40 M | $806.40 M |
FAQ
- What is Abbott Laboratories annual total current liabilities?
- What is the all time high annual current liabilities for Abbott Laboratories?
- What is Abbott Laboratories annual current liabilities year-on-year change?
- What is Abbott Laboratories quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Abbott Laboratories?
- What is Abbott Laboratories quarterly current liabilities year-on-year change?
What is Abbott Laboratories annual total current liabilities?
The current annual current liabilities of ABT is $13.84 B
What is the all time high annual current liabilities for Abbott Laboratories?
Abbott Laboratories all-time high annual total current liabilities is $17.26 B
What is Abbott Laboratories annual current liabilities year-on-year change?
Over the past year, ABT annual total current liabilities has changed by -$1.65 B (-10.64%)
What is Abbott Laboratories quarterly total current liabilities?
The current quarterly current liabilities of ABT is $14.90 B
What is the all time high quarterly current liabilities for Abbott Laboratories?
Abbott Laboratories all-time high quarterly total current liabilities is $17.26 B
What is Abbott Laboratories quarterly current liabilities year-on-year change?
Over the past year, ABT quarterly total current liabilities has changed by +$1.86 B (+14.26%)